Product Information
CINACALCET HCL 90 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $1.0621 per EA under NDC 76282067630. Its NADAC has been published 304 times since Dec 9, 2020.
FDA first approved this application on Mar 8, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
90 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282067630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CINACALCET HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208915FDA Approved
3/8/2018
TE Code
AB
On Market Since
4/14/2020
Pharmacological Classes
Price Statistics
The NADAC for CINACALCET HCL 90 MG TABLET has been published 304 times since Dec 9, 2020, and over the history we have for it it has declined 92.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0621 per EA |
|---|---|
| All-time high | $13.3879 (Dec 16, 2020) |
| All-time low | $0.6600 (May 22, 2024) |
| 52-week high | $1.0621 |
| 52-week low | $0.8018 |
| Median price | $0.9990 |
| Average price | $2.3590 |
| Largest weekly change | -70.1% (Jun 22, 2022) |
| Weeks tracked | 304 |
| Tracking since | Dec 9, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CINACALCET market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium-sensing Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CINACALCET HCL 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CINACALCET HCL 90 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $1.0621 per EA (NDC 76282067630), effective Sep 30, 2026.
How has the price of CINACALCET HCL 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for CINACALCET HCL 90 MG TABLET has declined 92.1%. It has been tracked across 304 weekly CMS publications since Dec 9, 2020.
What are the highest and lowest recorded NADAC prices for CINACALCET HCL 90 MG TABLET?
Since Dec 9, 2020, the NADAC for CINACALCET HCL 90 MG TABLET has ranged from a low of $0.6600 (May 22, 2024) to a high of $13.3879 (Dec 16, 2020), with a median of $0.9990 per EA.
Are there cheaper alternatives to CINACALCET HCL 90 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CINACALCET HCL 90 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CINACALCET HCL 90 MG TABLET?
CINACALCET HCL 90 MG TABLET (NDC 76282067630) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.